| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.3M | +23.2% |
| Cost of Revenue | $47.2M | +25.0% |
| Gross Profit | $98K | -84.5% |
| R&D Expense | $326K | -39.5% |
| SG&A Expense | $12.6M | +132.5% |
| Operating Income | -$13.6M | -138.4% |
| Pre-tax Income | -$2.5M | +50.6% |
| Income Tax | $177K | +23.8% |
| Net Income | -$2.8M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | +66.9% |
| Accounts Receivable | $3.4M | +42.9% |
| Current Assets | $19.9M | +54.6% |
| Total Assets | $32.6M | +57.9% |
| Current Liabilities | $8.8M | +10.0% |
| Total Liabilities | $10.9M | +32.7% |
| Stockholders' Equity | $21.8M | +73.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -2811.0% |
| Capital Expenditures | $334K | — |
| Investing Cash Flow | -$5.5M | -57.5% |
| Financing Cash Flow | $17.1M | +194.3% |
| Free Cash Flow | -$9.2M | -2913.5% |
| +47.2% |